These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17554476)

  • 1. Allelic variation in the NPY gene in 14 Indian populations.
    Bhaskar LVKS; Thangaraj K; Shah AM; Pardhasaradhi G; Praveen Kumar K; Reddy AG; Papa Rao A; Mulligan CJ; Singh L; Rao VR
    J Hum Genet; 2007; 52(7):592-598. PubMed ID: 17554476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease.
    Masoudi-Kazemabad A; Jamialahmadi K; Moohebati M; Mojarrad M; Dehghan-Manshadi R; Forghanifard MM; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M
    Gene; 2012 Mar; 496(1):22-7. PubMed ID: 22289186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States.
    Lappalainen J; Kranzler HR; Malison R; Price LH; Van Dyck C; Rosenheck RA; Cramer J; Southwick S; Charney D; Krystal J; Gelernter J
    Arch Gen Psychiatry; 2002 Sep; 59(9):825-31. PubMed ID: 12215082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
    Sjöholm LK; Melas PA; Forsell Y; Lavebratt C
    J Affect Disord; 2009 Nov; 118(1-3):124-30. PubMed ID: 19264362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
    Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations.
    Zhu G; Pollak L; Mottagui-Tabar S; Wahlestedt C; Taubman J; Virkkunen M; Goldman D; Heilig M
    Alcohol Clin Exp Res; 2003 Jan; 27(1):19-24. PubMed ID: 12544000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between neuropeptide Y gene polymorphisms and alcohol dependence: a case-control study in two independent populations.
    Bhaskar LV; Thangaraj K; Kumar KP; Pardhasaradhi G; Singh L; Rao VR
    Eur Addict Res; 2013; 19(6):307-13. PubMed ID: 23652361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation and haplotype structure of the dopamine receptor gene DRD2 in nine Indian populations.
    Bhaskar LV; Thangaraj K; Mulligan CJ; Rao AP; Pardhasaradhi G; Kumar KP; Shah AM; Sabeera B; Reddy AG; Singh L; Rao VR
    Genet Test; 2008 Mar; 12(1):153-60. PubMed ID: 18373412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
    Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
    Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
    Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
    Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
    Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
    Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrient intake, weight, and Leu7Pro polymorphism in prepro-neuropeptide Y in children.
    Karvonen MK; Ruottinen S; Koulu M; Pesonen U; Niinikoski H; Rask-Nissilä L; Simell O; Rönnemaa T
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4664-8. PubMed ID: 16912140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y gene polymorphisms are not associated with obesity in a South Indian population.
    Bhaskar LV; Thangaraj K; Pardhasaradhi G; Kumar KP; Singh L; Rao VR
    Eur J Clin Nutr; 2010 Aug; 64(8):868-72. PubMed ID: 20531438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
    Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
    Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
    Ma J; Nordman S; Möllsten A; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
    Eur J Endocrinol; 2007 Nov; 157(5):641-5. PubMed ID: 17984244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration.
    Kaarniranta K; Holopainen JM; Karvonen MK; Koulu M; Kallio J; Pesonen U; Teräsvirta M; Uusitalo H; Immonen I
    Acta Ophthalmol Scand; 2007 Mar; 85(2):188-91. PubMed ID: 17305733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.